Status:
COMPLETED
Safety and Effectiveness Study of the Solysafe Septal Occluder
Lead Sponsor:
Carag AG
Conditions:
Atrial Septal Defects
Eligibility:
All Genders
2+ years
Phase:
NA
Brief Summary
Prospective mono-center clinical study to evaluate the safety and effectiveness of an intracardiac septal closure device in patients with atrial septum defect (ASD)
Eligibility Criteria
Inclusion
- ASD
Exclusion
- Criteria that exclude catheterization (e.g. too small size, DIC, high risk of bleeding such as coagulation or clotting disorders)
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00353509
Last Update
October 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Childen's Hospital
Belgrade, Serbia, 11000